Thor Medical ASA (OSL:TRMED)

Market Cap	2.49B +159.1%
Revenue (ttm)	839.00K
Net Income	-58.01M
EPS	-0.17
Shares Out	360.00M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,490,985
Open	6.70
Previous Close	6.69
Day's Range	6.68 - 6.95
52-Week Range	2.70 - 6.94
Beta	-0.23
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About Thor Medical ASA

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It offers thorium-228, as well as radium-224 and lead-212 to radiopharmaceutical customers. The company was incorporated in 2009 and is headquartered in Oslo, Norway.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2009
• Employees: 18
• Stock Exchange: Oslo Børs
• Ticker Symbol: TRMED

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 24, 2026

Data Sources Report a data error